0001209191-20-048037.txt : 20200901
0001209191-20-048037.hdr.sgml : 20200901
20200824120326
ACCESSION NUMBER: 0001209191-20-048037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200819
FILED AS OF DATE: 20200821
DATE AS OF CHANGE: 20200901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abney Michael Donald Jr.
CENTRAL INDEX KEY: 0001631320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 201125863
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-19
0
0000353569
QUIDEL CORP /DE/
QDEL
0001631320
Abney Michael Donald Jr.
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP - Distribution
Common Stock
2020-08-19
4
M
0
2335
21.08
A
8969
D
Common Stock
2020-08-19
4
M
0
3275
46.41
A
12244
D
Common Stock
2020-08-19
4
S
0
5610
250.00
D
6634
D
Common Stock
2020-08-20
4
M
0
1251
21.08
A
7885
D
Common Stock
2020-08-20
4
M
0
1331
46.41
A
9216
D
Common Stock
2020-08-20
4
S
0
2582
250.00
D
6634
D
Non-Qualified Stock Options
21.08
2020-08-19
4
M
0
2335
0.00
D
2027-02-15
Common Stock
2335
4836
D
Non-Qualified Stock Options
46.41
2020-08-19
4
M
0
3275
0.00
D
2028-01-16
Common Stock
3275
5937
D
Non-Qualified Stock Options
21.08
2020-08-20
4
M
0
1251
0.00
D
2027-02-15
Common Stock
1251
3585
D
Non-Qualified Stock Options
46.41
2020-08-20
4
M
0
1331
0.00
D
2018-01-16
Common Stock
1331
4606
D
7,172 shares vested on the second anniversary date of the grant date, February 15, 2019. 3,586 shares vested on the third anniversary date of the grant date, February 15, 2020. 3,585 shares will vest on the fourth anniversary date of the grant date.
4,606 shares vested on the second anniversary date of the grant date, January 16, 2020. 2,303 shares will vest on the third anniversary date of the grant date, January 16, 2021. 2,303 shares will vest on the fourth anniversary date of the grant date, January 17, 2022.
All transactions reported herein were effected pursuant to a pre-established 10b5-1 trading plan.
Robert J. Bujarski, attorney-in-fact for Michael D. Abney Jr.
2020-08-21